★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★

Checking

Intuitive Surgical, Inc.

ISRG · NASDAQ

Market cap (USD)$143B
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Request update

Spot something outdated? Send a quick note and source so we can refresh this profile.

Overview

Intuitive Surgical provides robotic-assisted surgery platforms and monetizes a large installed base through instruments, accessories, leases and service contracts. Although it reports one operating segment, this record is segmented by disclosed revenue categories. The clearest moat is the proprietary installed-base consumables model, reinforced by training sunk costs and a global OEM field-service footprint. System price and installed-base scale did not alone prove a manufacturing know-how moat; a long sales cycle did not prove procurement inertia; broad ecosystem and analytics descriptions did not prove separate lock-in; counterfeit risk did not establish an IP choke point; and generally renewed service contracts were not shown to be long-term. Key risks include well-capitalized medtech entrants, domestic Chinese competitors, policy shifts enabling third-party servicing or consumables, reprocessing, tariffs, and hospital cost pressure.

Primary segment

Instruments and Accessories

Market structure

Monopoly

Market share

HHI:

Coverage

3 segments · 8 tags

Updated 2026-07-12

Segments

Systems

Robotic-assisted surgical systems for minimally invasive soft-tissue and endoluminal procedures

Revenue

23.5%

Structure

Quasi-Monopoly

Pricing

moderate

Share

Peers

MDTJNJSYKZBH+2

Instruments and Accessories

Proprietary robotic surgery instruments, accessories, and consumables used per procedure on the da Vinci (and Ion) installed base

Revenue

60.9%

Structure

Monopoly

Pricing

strong

Share

Peers

MDTJNJSYKSNN+1

Services

Service contracts, maintenance, and uptime and monitoring services for the da Vinci and Ion installed base

Revenue

15.7%

Structure

Monopoly

Pricing

moderate

Share

Peers

MDTJNJSYKSNN+1

Moat Claims

Systems

Robotic-assisted surgical systems for minimally invasive soft-tissue and endoluminal procedures

Revenue share computed from Q1 2026 disaggregated revenue: Systems $650.7M of total $2.7708B.

Quasi-Monopoly

Training Org Change Costs

Demand

Strength

Strength 3 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 2 of 5

Role-based training pathways and simulation tools (with tracking) raise organizational adoption and switching costs for surgeons, residents, and OR teams.

Training Org Change Costs moat: definition, examples, and stocks

Erosion risks

  • Surgeons increasingly train on multiple vendors (multi-homing)
  • Standardized credentialing and third-party training reduces differentiation
  • Remote proctoring lowers the friction of switching platforms

Leading indicators

  • Utilization of Intuitive Learning / SimNow platforms
  • Adoption speed for new system generations at existing sites
  • Share of procedures from newly trained surgeons

Counterarguments

  • Hospitals regularly retrain staff and may switch if ROI is compelling
  • Newer surgeons may be less loyal to a single platform over their careers

Instruments and Accessories

Proprietary robotic surgery instruments, accessories, and consumables used per procedure on the da Vinci (and Ion) installed base

Revenue share computed from Q1 2026 disaggregated revenue: Instruments and accessories $1.6864B of total $2.7708B.

Monopoly

Installed Base Consumables

Demand

Strength

Strength 5 of 5

Durability

Durability 3 of 3

Confidence

Confidence 5 of 5

Evidence

Evidence 2 of 5

Per-procedure instruments and accessories are largely tied to Intuitive platforms and are limited-use, creating a durable recurring revenue stream proportional to procedure volume.

Installed Base Consumables moat: definition, examples, and stocks

Erosion risks

  • Third-party reprocessing and remanufacturing reduces instrument replacement rates
  • Procedure growth slows or shifts to alternative modalities
  • Pricing pressure from large IDNs and GPOs and hospital cost containment

Leading indicators

  • Instruments and accessories revenue per procedure
  • Global procedure growth and procedure mix by specialty
  • Penetration of reprocessed and third-party instruments (where permitted)

Counterarguments

  • Hospitals can push back on consumables pricing and extend life via reprocessing
  • If competing platforms gain placements, consumables attach can shift away over time

Services

Service contracts, maintenance, and uptime and monitoring services for the da Vinci and Ion installed base

Revenue share computed from Q1 2026 disaggregated revenue: Services $433.7M of total $2.7708B.

Monopoly

Service Field Network

Supply

Strength

Strength 3 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 1 of 5

A dense field service network plus 24/7 support and proactive monitoring supports high uptime and reinforces service renewals for mission-critical OR equipment.

Service Field Network moat: definition, examples, and stocks

Erosion risks

  • Third-party service providers compete on price or coverage
  • Right-to-repair and parts access regulation expands
  • Cybersecurity incidents disrupt connected monitoring

Leading indicators

  • Service contract renewal and attach rates
  • System uptime and unplanned downtime incidence
  • Service gross margin and cost-to-serve trends

Counterarguments

  • Large hospital systems may build in-house biomedical engineering capacity or use third parties
  • Competitors can bundle aggressive service terms with new system placements

Evidence

sec_filing

Intuitive provides a progressive learning journey

Shows structured training offerings embedded in adoption.

sec_filing

The SimNow online connection drives real-time simulation performance tracking

Training with measurable progression and analytics increases organizational stickiness.

sec_filing

between $900 and $3,700 of instruments and accessories revenue per surgical procedure

Direct evidence that each procedure drives recurring consumables revenue.

sec_filing

Total recurring revenue $ 2,370.3

Q1 2026 recurring revenue was 86% of total revenue, supporting installed-base monetization.

sec_filing

We have a network of field service engineers across the U.S., Canada, Europe, and Asia

Direct evidence of service footprint and uptime-oriented support model.

Risks & Indicators

Erosion risks

  • Surgeons increasingly train on multiple vendors (multi-homing)
  • Standardized credentialing and third-party training reduces differentiation
  • Remote proctoring lowers the friction of switching platforms
  • Third-party reprocessing and remanufacturing reduces instrument replacement rates
  • Procedure growth slows or shifts to alternative modalities
  • Pricing pressure from large IDNs and GPOs and hospital cost containment

Leading indicators

  • Utilization of Intuitive Learning / SimNow platforms
  • Adoption speed for new system generations at existing sites
  • Share of procedures from newly trained surgeons
  • Instruments and accessories revenue per procedure
  • Global procedure growth and procedure mix by specialty
  • Penetration of reprocessed and third-party instruments (where permitted)

Keep the research going

Created 2025-12-30
Updated 2026-07-12

More Rankings & Systems

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.